| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e7a9f9b6aa26ac3a15dfb7b4c82bc2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d291750f5e3646d47c0fd7586abe94c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a8141c71fa3b9211d1b3bcc3e953b2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c684531bc11465b836b54b95f67799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19627d7a24f8d584f60a36b2b6d5f163 |
| publicationDate |
2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2980207-A1 |
| titleOfInvention |
Cell sorting method |
| abstract |
Provided is a pluripotent stem cell-derived differentiated cell with a reduced tumor risk. A method of removing or reducing undifferentiated cells from a differentiated cell population contaminated or having a risk of contamination with undifferentiated cells, including contacting a pigment epithelium-derived factor with the differentiated cell population to induce apoptosis of the undifferentiated cells. An agent for cell transplantation therapy, containing a differentiated cell population substantially free of an undifferentiated cell, which is obtained by the method. An agent for inducing apoptosis of an undifferentiated cell, containing a pigment epithelium-derived factor. Combined use of the aforementioned agent for cell transplantation therapy and the aforementioned agent for inducing apoptosis. |
| priorityDate |
2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |